Terry Smith Fundsmith LLP
Terry Smith is the founder and CEO of Fundsmith, a firm known for a concentrated portfolio of high-quality global companies. His approach favors simple, understandable businesses with high returns on capital and the ability to reinvest at attractive rates. Smith’s annual letters and plain-spoken commentary have made Fundsmith a frequent reference point for long-only quality investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medpace
MEDP
|
+$43.3M |
| 2 |
Doximity
DOCS
|
+$34.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$363M |
| 2 |
Microsoft
MSFT
|
+$304M |
| 3 |
Visa
V
|
+$278M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Automatic Data Processing
ADP
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.66% |
| 2 | Healthcare | 22.21% |
| 3 | Consumer Staples | 18.08% |
| 4 | Communication Services | 16.91% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Equifax
EFX
$22.6B
| $92.6M | 0.39% |
363,328
| – | – |
|
27
Sabre
SABR
$848M
| $78.5M | 0.33% |
21,499,095
| – | – |
|
28
Qualys
QLYS
$6.3B
| $76.8M | 0.33% |
548,009
| – | – |
|
29
IDEX
IEX
$17.3B
| $75.9M | 0.32% |
362,501
| – | – |
|
30
Exponent
EXPO
$3.34B
| $74.5M | 0.32% |
836,477
| – | – |
|
31
Rollins
ROL
$17.8B
| $74M | 0.32% |
1,597,513
| – | – |
|
32
ODDITY Tech
ODD
$610M
| $67.9M | 0.29% |
1,615,158
| – | – |
|
33
Paycom
PAYC
$10.3B
| $66.1M | 0.28% |
322,611
| – | – |
|
34
Home Depot
HD
$335B
| $56.7M | 0.24% |
145,639
-2,176
| -1% | -$889K |
|
|
35
Medpace
MEDP
$17.3B
| $42.4M | 0.18% |
+127,537
| New | +$43.3M |
|
|
36
Doximity
DOCS
$4.51B
| $37.9M | 0.16% |
+710,502
| New | +$34.8M |
|
37
Zoetis
ZTS
$32.1B
| $37M | 0.16% |
227,329
-3,397
| -1% | -$608K |
|
38
Mastercard
MA
$509B
| $33.7M | 0.14% |
64,033
-957
| -1% | -$495K |
|
|
39
Apple
AAPL
$4.51T
| – | – |
-1,558,589
| Closed | -$363M |
|
40
Cognex
CGNX
$10.2B
| – | – |
-1,906,276
| Closed | -$77.2M |
|
41
McDonald's
MCD
$192B
| – | – |
-94,403
| Closed | -$28.7M |
|
42
McCormick & Company Non-Voting
MKC
$14.9B
| – | – |
-1,728,157
| Closed | -$142M |
|
Similar funds
Terry Smith's Q4 2024 Portfolio in Review
As of Q4 2024, Terry Smith held 42 positions worth $23.5B, down 7.2% from $25.3B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Terry Smith withdrew a net $1.78B in Q4 2024, closing 4 positions and reducing 21 holdings. Its most notable exit was Apple, an estimated $363M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Terry Smith opened a new position in Medpace worth $42.4M.
- Terry Smith's largest Q4 2024 buy was Medpace: 127,537 shares worth $42.4M.
- Terry Smith's biggest Q4 2024 reduction was Microsoft, cutting an estimated $304M.
- Terry Smith fully exited Apple in Q4 2024, selling an estimated $363M.
- Terry Smith's ten largest holdings make up 70% of its $23.5B portfolio in Q4 2024.
- Terry Smith opened 2 new positions and closed 4 in Q4 2024.
- Terry Smith's portfolio value fell 7.2% quarter-over-quarter to $23.5B.
Based on Fundsmith LLP's 13F filing for Q4 2024, filed 14 Feb 2025.